Effects of Intrinsic Subtypes and 21-gene Assay on the Early and Late Recurrence Risks in Patients with Early Stage HER2+ Breast Cancer: An Analysis of the North Central Cancer Treatment Group (NCCTG) N9831 (Alliance) Trial
- Citation:
- Cancer Research vol 83 (5_suppl) abstr P2-11-05
- Meeting Instance:
- SABCS 2022
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Genentech
- Grants:
- BCRF-19-161, U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Saranya Chumsri Zhuo Li Nadine Norton Alvaro Moreno-Aspitia Gerardo Colon-Otero Keith L. Knutson Antonio Wolff Edith A. Perez E.A. Thompson
- Networks:
- LAPS-MD017, LAPS-MN026, NY021, PR028
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: